Critically, many compounded semaglutide products contain salt forms like semaglutide sodium or acetate, which are not part of FDA-approved formulations and lack safety or efficacy data
Members receive protocol updates, comparative analyses, and practical guidance for evaluating emerging options as they become available
The FDA approved tirzepatide for treating type 2 diabetes last year and for treating obesity in November, under the brand name Zepbound
When to seek medical advice : Contact your healthcare provider if you experience severe injection site reactions (extensive swelling, severe pain, signs of infection), systemic symptoms following injection (difficulty breathing, widespread rash, dizziness), severe or persistent abdominal pain, or consistent problems with injection technique despite training
Conflict of interest The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest